YD Bio (NASDAQ:YDES) Shares Gap Up – Should You Buy?

YD Bio Limited (NASDAQ:YDES) shares gapped up before the market opened on Friday . The stock had previously closed at $9.03, but opened at $9.46. YD Bio shares last traded at $9.20, with a volume of 6,447 shares traded.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen upgraded shares of YD Bio to a “sell” rating in a research note on Tuesday, November 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

YD Bio Price Performance

The firm’s 50 day simple moving average is $11.11.

Hedge Funds Weigh In On YD Bio

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC increased its position in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent reporting period.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.